Article(id=1322906904489501180, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1611763200000, acceptedDateStr=2021-01-28, onlineDate=1793335184451, onlineDateStr=2026-10-30, pubDate=1636905600000, pubDateStr=2021-11-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793335184451, onlineIssueDateStr=2026-10-30, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793335184451, creator=13701087609, updateTime=1793335184451, updator=13701087609, issue=Issue{id=1322887411688919265, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='21', pageStart='1921', pageEnd='2016', issueExtLink='null', onlineDate='null', pubDate='1636905600000', pubDateStr='2021-11-15', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793330537006, creator='13701087609', updateTime=1793337443794, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322916380919608076, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322916380919608077, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1934, endPage=1939, ext={EN=ArticleExt(id=1322906904778908157, articleId=1322906904489501180, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Pharmacology and clinical evaluation of the RNA polymerase Ⅱ inhibitor lurbinectedin, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Lurbinectedin is an RNA polymerase Ⅱ inhibitor that inhibits oncogene transcription in tumor-associated macrophages. It belongs to an injectable alkylated drug that can be used for the treatment of small cell lung cancer (SCLC) in adult patients with disease progression during or after platinum chemotherapy. The common adverse reactions include reversible myelosuppression and liver toxicity. This review summarizes pharmacology, clinical evaluation, drug interaction, safety, pharmacokinetics and dosage regarding this drug.

, authors=Hua LAN, Ya-tong ZHANG, Yang WANG, authorsList=Hua LAN, Ya-tong ZHANG, Yang WANG, authorCompany=null, correspAuthors=Ya-tong ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322906905043149310, articleId=1322906904489501180, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=RNA聚合酶Ⅱ抑制剂lurbinectedin的药理作用与临床评价, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

lurbinectedin是一种RNA聚合酶Ⅱ抑制剂,可抑制肿瘤相关巨噬细胞的致癌基因转录,属于注射用烷基化药物,可用于治疗铂类化疗治疗中或治疗后疾病进展的小细胞肺癌(SCLC)成年患者。本品常见的不良反应有可逆性骨髓抑制和肝毒性。本文对其药理学、临床评价、药物相互作用、安全性、药动学及用法用量进行综述。

, authors=蓝花, 张亚同, 王洋, authorsList=蓝花, 张亚同, 王洋, authorCompany=null, correspAuthors=张亚同, authorNote=

蓝花,女,药师,主要从事医院药学工作。E-mail:。

, correspAuthorsNote=
张亚同,男,副主任药师,硕士,研究方向:临床药学。联系电话:(010)85132114,E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=ikVncrINuNYo3YswW1CEPg==, magXml=jurkTssozh6LXeepHjL19A==, pdfUrl=null, pdf=q7Ic6W4Zv/6b7Oh7Lt5uIA==, pdfFileSize=946324, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=gUw6weZ5w/KBr5SIVVN+NA==, mapNumber=null, fund=null)}, authors=[Author(id=1322906905361916419, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=18345146081@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906905441608197, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905361916419, language=EN, stringName=Hua LAN, firstName=Hua, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906905500328454, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905361916419, language=CN, stringName=蓝花, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio={"content":"

蓝花,女,药师,主要从事医院药学工作。E-mail:。

"}, bioImg=null, bioContent=

蓝花,女,药师,主要从事医院药学工作。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])]), Author(id=1322906905571631624, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zyt2002888@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906905638740490, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905571631624, language=EN, stringName=Ya-tong ZHANG, firstName=Ya-tong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906905705849355, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905571631624, language=CN, stringName=张亚同, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])]), Author(id=1322906905890398733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906905999450639, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905890398733, language=EN, stringName=Yang WANG, firstName=Yang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906906070753808, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905890398733, language=CN, stringName=王洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])])], keywords=[Keyword(id=1322906906184000017, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=EN, orderNo=1, keyword=lurbinectedin), Keyword(id=1322906906263691794, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=EN, orderNo=2, keyword=small cell lung cancer (SCLC)), Keyword(id=1322906906318217747, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=EN, orderNo=3, keyword=RNA polymerase Ⅱ inhibitor), Keyword(id=1322906906381132308, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=EN, orderNo=4, keyword=pharmacological action), Keyword(id=1322906906456629781, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=EN, orderNo=5, keyword=clinical evaluation), Keyword(id=1322906906527932950, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=CN, orderNo=1, keyword=lurbinectedin), Keyword(id=1322906906599236119, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=CN, orderNo=2, keyword=小细胞肺癌), Keyword(id=1322906906666344984, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=CN, orderNo=3, keyword=RNA聚合酶Ⅱ抑制剂), Keyword(id=1322906906737648153, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=CN, orderNo=4, keyword=药理作用), Keyword(id=1322906906813145626, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, language=CN, orderNo=5, keyword=临床评价)], refs=[Reference(id=1322906908524421659, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=TORRE LA, BRAY F, SIEGEL RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108., articleTitle=null, refAbstract=null), Reference(id=1322906908604113436, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=王玮. 浅析我国的药品专利期限补偿制度[J]. 中国医药工业杂志, 2021, 52(1): 143-146., articleTitle=null, refAbstract=null), Reference(id=1322906908679610909, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=JALAL SI, LAVIN P, LO G, et al. Carboplatin and etoposide with or without palifosfamide in untreated extensive-stage small-cell lung cancer: a multicenter, adaptive, randomized phase Ⅲ study (MATISSE)[J]. Clin Oncol, 2017, 35(23): 2619-2623., articleTitle=null, refAbstract=null), Reference(id=1322906908750914078, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=TISEO M, BONI L, AMBROSIO F, et al. Italian, multicenter, phase Ⅲ, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer: the GOIRC-AIFA FARM6PMFJM trial[J]. Clin Oncol, 2017, 35(12): 1281-1287., articleTitle=null, refAbstract=null), Reference(id=1322906908830605855, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=RECK M, LUFT A, SZCZESNA A, et al. Phase Ⅲ randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer[J]. Clin Oncol, 2016, 34(31): 3740-3748., articleTitle=null, refAbstract=null), Reference(id=1322906908922880544, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=VIDETIC GMM, STITT LW, DAR AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival[J]. J Clin Oncol, 2003, 8(25): 1544-1549., articleTitle=null, refAbstract=null), Reference(id=1322906908989989409, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=NCCN Clinical Practice Guidelines in Small Cell Lung Cancer (2020 Version Ⅲ)[EB/OL]. (2020-02-11). http://www.nccn.org., articleTitle=null, refAbstract=null), Reference(id=1322906909057098274, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=TRIGO J, SUBBIAH V. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial[J]. Lancet Oncol, 2020 21(5): 645-654., articleTitle=null, refAbstract=null), Reference(id=1322906909120012835, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=张良, 刘显红, 柳影, 等. 三药联合化疗和单药拓扑替康二线治疗小细胞肺癌的疗效和安全性比较[J]. 中国肿瘤临床, 2019, 46(3): 133-137., articleTitle=null, refAbstract=null), Reference(id=1322906909203898916, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=OWONIKOKO TK, BEHERA M, CHEN Z, et al. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer[J]. J Thorac Oncol, 2012, 7(5): 866-872., articleTitle=null, refAbstract=null), Reference(id=1322906909271007781, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Lurbinectedin[EB/OL]. (2020). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213702s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1322906909354893862, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=邸明一, 张力. 小细胞肺癌药物治疗进展[J]. 中国肿瘤临床, 2016, 43(10): 418-423., articleTitle=null, refAbstract=null), Reference(id=1322906909422002727, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=SANTAMARIA NUNEZ G, ROBLES CM, GIRAUDON C, et al. Lurbinectedin specifically triggers the degradation of phosphorylated RNA polymerase Ⅱ and the formation of DNA breaks in cancer cells[J]. Mol Cancer Ther, 2016, 15(10): 2399-2412., articleTitle=null, refAbstract=null), Reference(id=1322906909489111592, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KAUFFMANN-GUERRERO D, HUBER RM. Orphan drugs in development for the treatment of small-cell lung cancer: emerging data on lurbinectedin[J]. Lung Cancer (Auckl), 2020, 11: 27-31., articleTitle=null, refAbstract=null), Reference(id=1322906909556220457, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=VON PAWEL J, SCHILLER JH, SHEPHERD FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer[J]. J Clin Oncol, 1999, 17(2): 658-667., articleTitle=null, refAbstract=null), Reference(id=1322906909614940714, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=VON PAWEL J, JOTTE R, SPIGEL DR, et al. Randomized Phase Ⅲ trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer[J]. J Clin Oncol, 2014, 32(35): 4012-4019., articleTitle=null, refAbstract=null), Reference(id=1322906909682049579, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=EVANS TL, CHO BC, UDUD K, et al. Cabazitaxel versus topotecan in patients with small-cell lung cancer with progressive disease during or after first-line platinum-based chemotherapy[J]. J Thorac Oncol, 2015, 10(8): 1221-1228., articleTitle=null, refAbstract=null), Reference(id=1322906909761741356, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=FORSTER M, OLMEDO ME, CALVO E, et al. “Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC).”[J]. Lung Cancer: J Int Assoc Study Lung Cancer, 2018, 115(Suppl 1): S72-S72., articleTitle=null, refAbstract=null), Reference(id=1322906909828850221, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=CALVO E, MORENO V, FLYNN M, et al. Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study[J]. Ann Oncol, 2017, 28(10): 2559-2566., articleTitle=null, refAbstract=null), Reference(id=1322906909891764782, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=CTCAE v4.0, Common Terminology Criteria for Adverse Events[EB/OL]. [2011-09-01]. http://WWW.Calgb.org/Public/meetings/presentations/2009/summer_group/cra-cont_ed/06a_CTCAE_Setser_062009.pdf., articleTitle=null, refAbstract=null), Reference(id=1322906909967262255, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=FARAGO AF, DRAPKIN BJ, LOPEZ-VILARINO DE RAMOS JA, et al. ATLANTIS: a phase Ⅲ study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line[J]. Fut Oncol, 2019, 15(3): 231-239., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I21/1934, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I21/1934, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I21/1934, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I21/1934, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1636905600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
RNA聚合酶Ⅱ抑制剂lurbinectedin的药理作用与临床评价
收藏切换
PDF下载
蓝花 , 张亚同 , 王洋
中国新药杂志 | 新药述评与论坛 2021,30(21): 1934-1939
收起
收藏切换
中国新药杂志 |新药述评与论坛 2021 , 30 (21) : 1934 -1939
RNA聚合酶Ⅱ抑制剂lurbinectedin的药理作用与临床评价
全屏
[Author(id=1322906905361916419, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=18345146081@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906905441608197, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905361916419, language=EN, stringName=Hua LAN, firstName=Hua, middleName=null, lastName=LAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906905500328454, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905361916419, language=CN, stringName=蓝花, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio={"content":"

蓝花,女,药师,主要从事医院药学工作。E-mail:。

"}, bioImg=null, bioContent=

蓝花,女,药师,主要从事医院药学工作。E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])]), Author(id=1322906905571631624, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zyt2002888@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906905638740490, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905571631624, language=EN, stringName=Ya-tong ZHANG, firstName=Ya-tong, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906905705849355, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905571631624, language=CN, stringName=张亚同, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])]), Author(id=1322906905890398733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906905999450639, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905890398733, language=EN, stringName=Yang WANG, firstName=Yang, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906906070753808, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, authorId=1322906905890398733, language=CN, stringName=王洋, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906905265447423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, xref=null, ext=[AuthorCompanyExt(id=1322906905278030336, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China), AuthorCompanyExt(id=1322906905286418945, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906904489501180, companyId=1322906905265447423, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730)])])]
蓝花 , 张亚同 , 王洋
作者信息
  • 北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730
通讯作者:
张亚同,男,副主任药师,硕士,研究方向:临床药学。联系电话:(010)85132114,E-mail:。
作者简介:

蓝花,女,药师,主要从事医院药学工作。E-mail:。

Pharmacology and clinical evaluation of the RNA polymerase Ⅱ inhibitor lurbinectedin
Hua LAN , Ya-tong ZHANG , Yang WANG
Affiliations
  • Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China
出版时间: 2021-11-15
文章导航
收藏切换

lurbinectedin是一种RNA聚合酶Ⅱ抑制剂,可抑制肿瘤相关巨噬细胞的致癌基因转录,属于注射用烷基化药物,可用于治疗铂类化疗治疗中或治疗后疾病进展的小细胞肺癌(SCLC)成年患者。本品常见的不良反应有可逆性骨髓抑制和肝毒性。本文对其药理学、临床评价、药物相互作用、安全性、药动学及用法用量进行综述。

lurbinectedin  /  小细胞肺癌  /  RNA聚合酶Ⅱ抑制剂  /  药理作用  /  临床评价

Lurbinectedin is an RNA polymerase Ⅱ inhibitor that inhibits oncogene transcription in tumor-associated macrophages. It belongs to an injectable alkylated drug that can be used for the treatment of small cell lung cancer (SCLC) in adult patients with disease progression during or after platinum chemotherapy. The common adverse reactions include reversible myelosuppression and liver toxicity. This review summarizes pharmacology, clinical evaluation, drug interaction, safety, pharmacokinetics and dosage regarding this drug.

lurbinectedin  /  small cell lung cancer (SCLC)  /  RNA polymerase Ⅱ inhibitor  /  pharmacological action  /  clinical evaluation
蓝花, 张亚同, 王洋. RNA聚合酶Ⅱ抑制剂lurbinectedin的药理作用与临床评价. 中国新药杂志, 2021 , 30 (21) : 1934 -1939 .
Hua LAN, Ya-tong ZHANG, Yang WANG. Pharmacology and clinical evaluation of the RNA polymerase Ⅱ inhibitor lurbinectedin[J]. Chinese Journal of New Drugs, 2021 , 30 (21) : 1934 -1939 .

参考文献 引证文献
排序方式:
[1]
TORRE LA, BRAY F, SIEGEL RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[2]
王玮. 浅析我国的药品专利期限补偿制度[J]. 中国医药工业杂志, 2021, 52(1): 143-146.
[3]
JALAL SI, LAVIN P, LO G, et al. Carboplatin and etoposide with or without palifosfamide in untreated extensive-stage small-cell lung cancer: a multicenter, adaptive, randomized phase Ⅲ study (MATISSE)[J]. Clin Oncol, 2017, 35(23): 2619-2623.
[4]
TISEO M, BONI L, AMBROSIO F, et al. Italian, multicenter, phase Ⅲ, randomized study of cisplatin plus etoposide with or without bevacizumab as first-line treatment in extensive-disease small-cell lung cancer: the GOIRC-AIFA FARM6PMFJM trial[J]. Clin Oncol, 2017, 35(12): 1281-1287.
[5]
RECK M, LUFT A, SZCZESNA A, et al. Phase Ⅲ randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer[J]. Clin Oncol, 2016, 34(31): 3740-3748.
[6]
VIDETIC GMM, STITT LW, DAR AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival[J]. J Clin Oncol, 2003, 8(25): 1544-1549.
[7]
NCCN Clinical Practice Guidelines in Small Cell Lung Cancer (2020 Version Ⅲ)[EB/OL]. (2020-02-11). http://www.nccn.org.
[8]
TRIGO J, SUBBIAH V. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial[J]. Lancet Oncol, 2020 21(5): 645-654.
[9]
张良, 刘显红, 柳影, 等. 三药联合化疗和单药拓扑替康二线治疗小细胞肺癌的疗效和安全性比较[J]. 中国肿瘤临床, 2019, 46(3): 133-137.
[10]
OWONIKOKO TK, BEHERA M, CHEN Z, et al. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer[J]. J Thorac Oncol, 2012, 7(5): 866-872.
[11]
FDA. Lurbinectedin[EB/OL]. (2020). https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213702s000lbl.pdf.
[12]
邸明一, 张力. 小细胞肺癌药物治疗进展[J]. 中国肿瘤临床, 2016, 43(10): 418-423.
[13]
SANTAMARIA NUNEZ G, ROBLES CM, GIRAUDON C, et al. Lurbinectedin specifically triggers the degradation of phosphorylated RNA polymerase Ⅱ and the formation of DNA breaks in cancer cells[J]. Mol Cancer Ther, 2016, 15(10): 2399-2412.
[14]
KAUFFMANN-GUERRERO D, HUBER RM. Orphan drugs in development for the treatment of small-cell lung cancer: emerging data on lurbinectedin[J]. Lung Cancer (Auckl), 2020, 11: 27-31.
[15]
VON PAWEL J, SCHILLER JH, SHEPHERD FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer[J]. J Clin Oncol, 1999, 17(2): 658-667.
[16]
VON PAWEL J, JOTTE R, SPIGEL DR, et al. Randomized Phase Ⅲ trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer[J]. J Clin Oncol, 2014, 32(35): 4012-4019.
[17]
EVANS TL, CHO BC, UDUD K, et al. Cabazitaxel versus topotecan in patients with small-cell lung cancer with progressive disease during or after first-line platinum-based chemotherapy[J]. J Thorac Oncol, 2015, 10(8): 1221-1228.
[18]
FORSTER M, OLMEDO ME, CALVO E, et al. “Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC).”[J]. Lung Cancer: J Int Assoc Study Lung Cancer, 2018, 115(Suppl 1): S72-S72.
[19]
CALVO E, MORENO V, FLYNN M, et al. Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study[J]. Ann Oncol, 2017, 28(10): 2559-2566.
[20]
CTCAE v4.0, Common Terminology Criteria for Adverse Events[EB/OL]. [2011-09-01]. http://WWW.Calgb.org/Public/meetings/presentations/2009/summer_group/cra-cont_ed/06a_CTCAE_Setser_062009.pdf.
[21]
FARAGO AF, DRAPKIN BJ, LOPEZ-VILARINO DE RAMOS JA, et al. ATLANTIS: a phase Ⅲ study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line[J]. Fut Oncol, 2019, 15(3): 231-239.
2021年第30卷第21期
PDF下载
7
1
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-30
  • 出版时间:2021-11-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2021-01-28
基金
作者信息
    北京医院药学部,国家老年医学中心,中国医学科学院老年医学研究所,北京 100730

通讯作者:

张亚同,男,副主任药师,硕士,研究方向:临床药学。联系电话:(010)85132114,E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322906904489501180
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏